The Lockheed Martin-backed satellite manufacturer is teaming up with Tailwind Two Acquisition Corp to list on the New York Stock Exchange.

The FedEx and SoftBank-backed shipping service provider’s offering, set to take place early next year, will reportedly value it between $5.5bn and $6bn.

The Amazon, Carrier, AGL Energy and Just Energy-backed smart thermostat producer is set to be taken over by Generac Holdings in a deal that could reach $770m.

Norgine, Axa and Debiopharm are in line for exits as the breast cancer diagnostics test provider is aiming to go public to boost research and development and commercial activities.

Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.

The Info Edge, Intel, Tencent and SoftBank-backed operator of insurance and financial products comparison tools PolicyBazaar and PaisaBazaar has gone public, having raised $343m in pre-IPO funding.

The Prosus and Benesse-backed online skills learning marketplace priced its shares at the top of their range to raise approximately $421m.

The Merck & Co and Roche-backed Duchenne muscular dystrophy drug developer has gone public in an upsized IPO sized at approximately $182m.

Henry Crown and Company achieved an exit as the root canal technology developer listed on the New York Stock Exchange below its IPO range.

Chiesi, Lundbeck and Li-Cor Biosciences scored exits as the oncology therapy developer floated in an upsized $75.6m initial public offering.